MDM2 and neoplasm: Nutlin-3, a well-established small molecule inhibitor of MDM2, was used as a negative control because it does not induce MDM2 degradation and thus, should not decrease [18F]1 uptake in the aforementioned tumor cell lines after an overnight treatment [14].